Registration - Consultant

Subject Matters

• Constitutional Issues
• Health
• Industry
• Intellectual Property
• Science and Technology

Subject Matter Details

Grant, Contribution or Other Financial Benefit

• National Immunization Strategy. Advocacy to seek continued funding in vaccines.

Legislative Proposal, Bill or Resolution

• Legislative proposals related to Canada's Food and Consumer Safety Action Plan. Merck Frosst Canada seeking to ensure that Canada's safety system for medicines ensures safe and effective medicines for Canadians in a timely manner, consistent with other jurisdictions.

Policies or Program

• Canada's Access to Medicine Regime (CAMR) and proposed amendments. Merck Frosst Canada seeking to ensure that those threatened by serious diseases have timely access to medicines for the diseases and that a research climate that will help to produce cures for other diseases is maintained.
• Health Canada's Blue Print for Renewal: Transforming Canada's Approach to Regulating Health Products and Food to renew the process for approving drugs. Merck Frosst Canada seeking to ensure that Canada's safety system for medicines ensures safe and effective medicines for Canadians in a timely manner, consistent with other jurisdictions.
• Patented Medicine Prices Review Board (PMPRB) Pricing Guidelines used by the PMPRB to ensure that prices of patented medicines sold in Canada are not excessive. Merck Frosst Canada seeking to ensure PMPRB Guidelines reflect their mandate of ensuring prices are non-excessive, while ensuring an attractive climate for pharmaceutical research.
• The Government's Science and Technology (S&T) Strategy announced in May 2007 which encourages a more competitive Canadian economy and improved quality of life for Canadians through science and technology. Merck Frosst seeking to ensure S&T Strategy encourages a more competitive environment for biopharmaceutical innovation in Canada.
• The National Pharmaceutical Strategy as agreed to by First Ministers in 2004, with a focus on options for catastrophic pharmaceutical coverage. Merck Frosst Canada seeking to ensure that Canadians' ability to access the medicines they need is increased.

Regulation

• Patented Medicine Prices Review Board (PMPRB) Regulations identifying information to be reported to the PMPRB. Merck Frosst Canada seeking to ensure that the information being collected is consistent with PMPRB's mandate to prevent excessive pricing while ensuring an attractive climate for pharmaceutical research.
• Patented Medicines (Notice of Compliance) Regulations which seek to balance patent rights and cost savings. Merck Frosst Canada seeking to ensure that patent rights are respected and are internationally competitive.

Communication Techniques

• Written communication
• Oral communication

Government Institutions

• Finance Canada (FIN)
• Health Canada (HC)
• House of Commons
• Industry Canada
• National Research Council (NRC)
• Patented Medicine Prices Review Board (PMPRB)
• Prime Minister's Office (PMO)
• Privy Council Office (PCO)
• Procurement Review Board of Canada (PRB)
• Public Health Agency of Canada (PHAC)
• Senate of Canada
• Treasury Board Of Canada Secretariat (TBS)

Address:
16711 TransCanada Highway
Kirkland, QC  H9H 3L1
Canada

Telephone number: 514-428-7920

Client representative

Carlos Dourado, President

Parent Company Information